Zoledronic Acid-Induced Orbital Inflammatory Disease
Preprint
- 16 February 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Bisphosphonates are a group of drugs that are used to prevent the loss of bone density and treat osteoporosis and similar bone diseases. Zoledronate (zolenedronic acid) has been increasingly used because of its advantages of intravenous infusion and annual regimens. Here, we present a case of zolendronic acid-related diffuse orbital inflammation. A 67-year-old woman with a history of breast cancer and chemotherapy developed severe unilateral orbital and periorbital swelling approximately 8 hours after receiving her first zoledronate infusion. In this case, the interval between infusion and the beginning of the symptoms was too short compared with most other reported similar cases. Her signs and symptoms relapsed 4 days after discontinuation of the short course of systemic steroid therapy. Orbital inflammation improved after systemic corticosteroid therapy was restarted, but the patient did not relapse following discontinuation of the drug in a tapering manner.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- ZoledronateBone, 2020
- Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood CellsCalcified Tissue International, 2013
- Orbital inflammation after zoledronate infusion: an emerging complicationCanadian Journal of Ophthalmology, 2013
- A 55‐year‐old woman with orbital inflammationArthritis Care & Research, 2012
- Safety of bisphosphonatesBone, 2011
- Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosisOsteoporosis International, 2009
- Orbital Inflammatory Disease After Intravenous Infusion of Zoledronate for Treatment of Metastatic Renal Cell CarcinomaArchives of Ophthalmology (1950), 2008
- Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side EffectsOphthalmology, 2004
- An In Vitro and In Vivo Study of Cytokines in the Acute-Phase Response Associated with BisphosphonatesCalcified Tissue International, 1997
- Pamidronate Disodium and Possible Ocular Adverse Drug ReactionsAmerican Journal of Ophthalmology, 1994